Literature DB >> 1829911

Malignant ascites: sonographic signs of peritoneal carcinomatosis.

C Goerg1, W B Schwerk.   

Abstract

This study was performed in 65 patients with cytologically proved malignant ascites to describe and classify direct and indirect sonographic signs of peritoneal carcinomatosis. Abdominal sonography revealed tumour-associated abnormalities which account for malignant ascites in 60 cases (92%). This includes visualisation of peritoneal metastases (n = 16, 25%); matting together of bowel loops (17, 26%); distribution of fluid (19, 29%); echoes within the fluid space (3, 5%); omental matting (8, 12%); associated masses (21, 32%); lymphoadenopathy (31, 48%); and hepatic metastases (26, 40%). Sonography enables the physician to demonstrate direct and indirect signs of peritoneal carcinomatosis in almost all tumour patients with ascites and is therefore useful in determining whether the cause of ascites is malignant or benign disease.

Entities:  

Mesh:

Year:  1991        PMID: 1829911     DOI: 10.1016/0277-5379(91)90173-b

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

1.  Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.

Authors:  Akiko Suzuki; Tsuyoshi Kawano; Nobukazu Takahashi; Jin Lee; Yoshihiro Nakagami; Etsuko Miyagi; Fumiki Hirahara; Shinji Togo; Hiroshi Shimada; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-16       Impact factor: 9.236

2.  ARFI elastography of the omentum: feasibility and diagnostic performance in differentiating benign from malignant omental masses.

Authors:  Amjad Alhyari; Christian Görg; Christoph Frank Dietrich; Corrina Trenker; Lena Strauch; Ehsan Safai Zadeh
Journal:  BMJ Open Gastroenterol       Date:  2022-05

3.  Detection of peritoneal metastases.

Authors:  J C Healy
Journal:  Cancer Imaging       Date:  2001-02-01       Impact factor: 3.909

4.  Difficulties in differentiating the nature of ascites based on ultrasound imaging.

Authors:  Andrzej Smereczyński; Katarzyna Kołaczyk; Elżbieta Bernatowicz
Journal:  J Ultrason       Date:  2017-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.